Article Details
Retrieved on: 2025-01-14 14:34:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Moss Genomics' dual listing on Canadian and Frankfurt Stock Exchanges, expanding capital market access and investor visibility in Europe. Forward-looking statements indicate expectations of growth aligning with U.S. securities regulations.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here